KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Zimmer Biomet Holdings (ZBH) Shares Outstanding (2022 - 2026)

Zimmer Biomet Holdings has reported Shares Outstanding over the past 11 years, most recently at $319.3 million for Q1 2026.

  • For Q1 2026, Shares Outstanding changed 0.28% year-over-year to $319.3 million; the TTM value through Mar 2026 reached $319.3 million, changed 0.28%, while the annual FY2025 figure was $318.7 million, 0.38% changed from the prior year.
  • Shares Outstanding for Q1 2026 was $319.3 million at Zimmer Biomet Holdings, roughly flat from $318.7 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $319.3 million in Q1 2026 and troughed at $313.6 million in Q3 2022.
  • A 5-year average of $316.9 million and a median of $317.2 million in 2024 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: grew 0.77% in 2023 and later grew 0.28% in 2026.
  • Year by year, Shares Outstanding stood at $313.8 million in 2022, then rose by 0.76% to $316.2 million in 2023, then grew by 0.41% to $317.5 million in 2024, then grew by 0.38% to $318.7 million in 2025, then increased by 0.19% to $319.3 million in 2026.
  • Business Quant data shows Shares Outstanding for ZBH at $319.3 million in Q1 2026, $318.7 million in Q4 2025, and $318.7 million in Q3 2025.